Serum 25-OH vitamin D and insulin resistance in women with polycystic ovary syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20230527Keywords:
PCOS, Fasting glucose, Fasting insulin, Insulin resistance, Vitamin DAbstract
Background: This was a prospective case control study conducted in the department of obstetrics and gynecology, Era’s Lucknow Medical College and Hospital from November 2018 to March 2020. Aim was to find whether there was a link between serum 25-OH vitamin D levels, and insulin resistance in women with polycystic ovarian syndrome (PCOS).
Methods: 30 newly diagnosed cases of PCOS and 30 women without PCOS were enrolled. Their clinical details as well as BMI and waist hip ratio were noted. The biochemical parameters which were measured included fasting glucose, fasting insulin, serum 25-OH vitamin D. The insulin resistance was calculated.
Results: 50% of the PCOS had insulin resistance and also deficient /or insufficient vitamin D levels, versus 16.7% in the control group. This association was statistically highly significant with p value as 0.00016. No statistical significance was found with regard to the mean serum 25-OH vitamin D level. 53.4%, of the PCOS women had hirsutism versus 3.3% in the control group and was statistically significant, p value <0.0001. 20% of PCOS women had acne in contrast to 3.3% in the control group which was statistically significant with p value 0.0443.
Conclusions: Hirsutism and acne were important clinical signs of PCOS. There was a negative correlation between insulin resistance and serum 25-OH vitamin D levels. Thus, vitamin D may be an important link in the genesis of PCOS. Larger randomised case control studies need to be done to understand PCOS.
Metrics
References
Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7(4):219-31.
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347-63.
Ketel IJ, Serne EH, Ijzerman RG, Korsen TJM, Twisk JW, Hompes PGA, et al. Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS. Hum Reprod. 2011;26(11):3130-7.
Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes. 1989;38(9):1165-74.
Nandi A, Sinha N, Ong E, Sonmez H, Poretsky L. Is there a role for vitamin D in human reproduction? Horm Mol Biol Clin Investig. 2016;25(1):15-28.
Ferder M, Inserra F, Manucha W, Ferder L. The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system. Am J Physiol. 2013;304:C1027-39.
Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabetic Med. 2008;25:320-5.
Vimaleswaran KS, Cavadino A, Berry DJ, Jorde R, Dieffenbach AK, Lu C, et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2014;2:719-29.
Chagas CE, Borges MC, Martini LA, Rogero MM. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012;4:52-67.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Handley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-30.
Esmaeilzadeh S, Tahmasbpour E, Gholinezhad-Chari M. Hyperhomocysteinemia, insulin resistance and body mass index in Iranian young women with polycystic ovary syndrome. Middle East Fertil Soc J. 2017;22(2):149-55.
Yadav S, Tarware R. (2019). Waist hip ratio: an anatomical predictive marker of risk of PCOS. Int J Reprod Contracept Obstet Gynecol. 2019;8:1630.
Kumar A, Barki S, Raghav V, Chaturvedi A, Kumar KH. Correlation of vitamin D with metabolic parameters in polycystic ovarian syndrome. J Fam Med Prim Care. 2017;6(1):115.
Gul OO, Ulutas F, Cander S, Ersoy C. Serum 25-Hydroxy vitamin D levels and insulin resistance in polycystic ovary syndrome. InEndocrine Abstracts. 2018;56:EP143.
Elkholy SS, Mostafa RA, Riad AA, AbouZaghla HM. Assessment of vitamin D levels in women with polycystic ovarian syndrome. Egypt J Hosp Med. 2018;70(4):594-600.
Kumar AN, Naidu JN, Satyanarayana U, Anitha M, Ramalingam K. Association of insulin resistance and serum 25-OH vitamin-D in Indian women with polycystic ovary syndrome. Int J Clin Biochem Res. 2015;2(1):22-6.
Saha PK, Pal S, Mukhopadhyay T. Association of vitamin D status with polycystic ovary syndrome in relation to insulin resistance and serum total testosterone. Int J Res Rev. 2019;6(6):11-7.
Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr. 2012;6(3):146-9.
HE C, Lin Z, Robb SW, Ezeamama AE. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015;7(6):4555-77.
Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32(3):195-201.
Wehr E, Trummer O, Giuliani A, Gruber HJ, Pieber TR, Obermayer-Pietsch B. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011;164(5):741.
Downloads
Published
How to Cite
Issue
Section
